CR MEDICAL (01515): Wang Yuexing appointed as executive director.
China Resources Healthcare Group (01515) announced that, starting from February 27, 2026, Ms. Yang Min has resigned as Executive Director and Chief Financial Officer, and Mr. Wang Yuexing has been appointed as Executive Director.
CR MEDICAL (01515) announced that Ms. Yang Min resigned as Executive Director and Chief Financial Officer starting from February 27, 2026; and Mr. Wang Yuexing was appointed as Executive Director.
Related Articles

STARCOIN GROUP (00399) has entered into a memorandum of understanding with Newbridge, a potential special purpose acquisition company, for a merger transaction and listing on the Nasdaq.

CN HEALTH TECH (01069) announced its interim financial results with a net profit of 5.252 million yuan, indicating a year-on-year growth of 5.5%.

MOKINGRAN (02585) issues profit warning, expecting a decrease of approximately 50% to 59% in net profit attributable to owners of the company for the year 2025.
STARCOIN GROUP (00399) has entered into a memorandum of understanding with Newbridge, a potential special purpose acquisition company, for a merger transaction and listing on the Nasdaq.

CN HEALTH TECH (01069) announced its interim financial results with a net profit of 5.252 million yuan, indicating a year-on-year growth of 5.5%.

MOKINGRAN (02585) issues profit warning, expecting a decrease of approximately 50% to 59% in net profit attributable to owners of the company for the year 2025.

RECOMMEND

Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026

Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026

AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026


